FAVIPAC Trademark

Trademark Overview


On Wednesday, September 21, 2022, a trademark application was filed for FAVIPAC with the United States Patent and Trademark Office. The USPTO has given the FAVIPAC trademark a serial number of 79369236. The federal status of this trademark filing is REGISTERED as of Tuesday, June 18, 2024. This trademark is owned by Pacific Pharmaceuticals Pte Ltd.. The FAVIPAC trademark is filed in the Pharmaceutical Products category with the following description:

Mineral dietary supplements for humans; pharmaceutical drugs, namely, anti-viral drugs in the nature of preparations for the treatment of Coronavirus infection
favipac

General Information


Serial Number79369236
Word MarkFAVIPAC
Filing DateWednesday, September 21, 2022
Status700 - REGISTERED
Status DateTuesday, June 18, 2024
Registration Number7416517
Registration DateTuesday, June 18, 2024
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, April 2, 2024

Trademark Statements


Goods and ServicesMineral dietary supplements for humans; pharmaceutical drugs, namely, anti-viral drugs in the nature of preparations for the treatment of Coronavirus infection

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 12, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePacific Pharmaceuticals Pte Ltd.
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressSG

Party NamePacific Pharmaceuticals Pte Ltd.
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressSG

Party NamePacific Pharmaceuticals Pte Ltd.
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressSG

Trademark Events


Event DateEvent Description
Friday, July 7, 2023NON-FINAL ACTION WRITTEN
Thursday, May 11, 2023SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, May 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 16, 2023APPLICATION FILING RECEIPT MAILED
Monday, July 3, 2023ASSIGNED TO EXAMINER
Saturday, July 8, 2023NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, August 15, 2023REFUSAL PROCESSED BY MPU
Tuesday, August 15, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 5, 2023REFUSAL PROCESSED BY IB
Wednesday, February 7, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 8, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 13, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 27, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 27, 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, April 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, September 18, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 18, 2024REGISTERED-PRINCIPAL REGISTER
Friday, February 23, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 16, 2024NOTIFICATION PROCESSED BY IB